R. Jugooa

Flow cytometric minimal residual disease assessment in B‐cell precursor acute lymphoblastic leukaemia patients treated with CD19‐targeted therapies — a EuroFlow study

E. Mejstrikova, A. Órfão, J. V. van Dongen, 2021, British journal of haematology.

Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial

P. Sonneveld, V. V. D. van der Velden, M. Boccadoro, 2021, Blood Cancer Journal.

Automated identification of leukocyte subsets improves standardization of database-guided expert-supervised diagnostic orientation in acute leukemia: a EuroFlow study

C. E. Pedreira, J. Miguel, M. Schilham, 2020, Modern Pathology.